Skip to main content
. 2023 Oct 31;4(2):100421. doi: 10.1016/j.xops.2023.100421

Figure 3.

Figure 3

Treatment patterns in the overall cohort for patients with at least 2 years of follow-up. A, Injection frequency over time as the mean number of anti-VEGF intravitreal injections. B, Interval between treatments as the mean number of weeks between injections over follow-up years 1 through 6.